Dr. Russell J Schilder M.D.
Oncologist | Medical Oncology
333 Cottman Ave Fox Chase Cancer Cen Philadelphia PA, 19111About
Dr. Russell Schilder is an oncologist practicing in Philadelphia, PA. Dr. Schilder specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Schilder manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Univ of Miami Sch of Med, Miami Fl 1983
University of Miami Leonard M. Miller School of Medicine 1983
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
- Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.
- Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
- Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study.
- Gynecological malignancies.
- Focus on epithelial ovarian cancer.
- Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin).
- Management of early-stage ovarian cancer.
- Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.
- Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma.
- Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
- Imatinib mesylate and its potential implications for gynecologic cancers.
- Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
- Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects.
- Relevant molecular markers and targets.
Treatments
- Breast Cancer
- Ovarian Cancer
- Wrinkle & Scar Improvement
Dr. Russell J Schilder M.D.'s Practice location
Dr. Russell J Schilder M.D.'s reviews
Write ReviewRecommended Articles
- What Impact Does Hospital Volume Have on Ovarian Cancer Survival?
Ovarian cancer is one of the most difficult cancers to treat. Though overall survival is generally over 90% if caught early, only about 15% of ovarian cancers are diagnosed at early stages. This means that many women are diagnosed with ovarian cancer at more advanced stages with high mortality.With...
- How Ovarian Cancer 'Previvors' Are Paving the Way
Nancy Crowe is a previvor, but she understands if someone doesn’t know what that means. It’s a relatively new term which arose in 2000 from a challenge posted on FORCE’s website. FORCE stands for Facing Our Risk of Cancer Empowered and was started by Sue Friedman in 1999.Sue says the goal of...
- Is Ovarian Cancer Terminal?
Let’s answer the question first: It depends on the stage of the disease. There are four stages of ovarian cancer, and the third and fourth are the most dangerous. The bad thing is that most cases of ovarian cancer are diagnosed in the later stages of the disease, when little can be done to save...
- Holistic Treatments for Liver Cancer
Holistic treatment for liver cancer indicates a science of healing that uses the person's whole spirit, mind and body. This treatment practice integrates the alternative and conventional therapies used to prevent and treat liver cancer, as well as promote the patient's wellbeing. The principle...
- What is Cancer Immunotherapy?
Immunotherapy, also referred as biological therapy, is a special type of cancer treatment aimed at boosting the body's immune system to help fight cancer cells. Cancer cells don’t die normally as other cells do, and divide uncontrollably with each cell making more of itself like a copy machine...
- Why This Lymphoma Patient Has A New Lease on Life
59-year-old Judy Wilkins, a mother of two and owner of a hair salon, had been battling lymphoma for years. The cancer became so aggressive that she tried four different chemotherapy regimens over a course of 18 months, with an aim to put it into remission. Nothing worked until CAR T-cell therapy....
Nearby Providers
- Dr. Vijay K. Gandhi M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Dr. Jon Glass MD909 Walnut St Philadelphia PA 19107
- Dr. Crystal S. Denlinger M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Eiko Klimant201 West Evergreen Avenue Philadelphia Pennsylvania 19118
- Dr. Shayma Master Kazmi MD1331 E Wyoming Ave Philadelphia PA 19124
- Dr. Angela R Bradbury MD333 Cottman Avenue Philadelphia PA 19111